Russell Banner

Already recruiting Dani, Welsh @swwcc patients are in. Open @VelindreCS

A day of celebration for 2 of our Glasgow H&N cancer (GlaHNC) research group members yesterday @UofGlasgow @UofGMVLS. 26 years after my 1st graduation it was great to be back to be awarded MD. Many congratulations to @CraigDSmith99 on his PhD 👏🏻 #hncsm

Here it is! KEYNOTE-689 primary publication online now @NEJM. It’s been an incredible journey with DAdkins @SitemanCenter @WUSM. All started in early 2010s / now with @US_FDA approval and a new standard of care! @DanaFarberNews @BrighamWomens @BrighamSurgery

Boom!💥 ⁦@FDA⁩ approves neoadjuvant and adjuvant pembrolizumab for resectable locally advanced head and neck squamous cell carcinoma, ushering in a new standard of care for the first time in decades. fda.gov/drugs/resource…

@DaniAkrigg @SWWCancerCentre Short answer is no we're not. healthtechnology.wales/reports-guidan…

Helping somebody going through diagnostic mill at the Singleton. Are you guys using PBM for HNC RT? I know you had a pretty ghastly trial at it years ago( or that might have been Cardiff) @SWWCancerCentre @drrsl

I had six weeks radiotherapy at the Singleton. My husband used to look forward to cake day. Me? I couldn’t eat so he had two helpings to make up for it. Lovely ladies. Well done. @SWWCancerCentre

This is a great group of engaged and motivated clinicians to be part of, all seeking to improve patient care as we deliver it in Wales. Thank you @BevanCommission for giving us the opportunity to learn from and quiz those who have gone before and given us tools to go further 👍

The problem is UK wide, and it's exacerbated regionally So a combined regional and national approach is essential for sustainability and equity of service to be achieved

Recruit Retain Train

This study reports on incredible results with adjuvant cemiplimab in high-risk cutaneous squamous cell carcinoma. #ap2" target="_blank" rel="nofollow noopener">nejm.org/doi/full/10.10…

Very powerful and insightful discussion by Prof Kevin Harrington @royalmarsden on KN-630 and C-POST The slides speak volumes and it isn’t just about the timing of anti-PD-1 😜 @KaramLab @CJTsaiMDPhD @seanmmcbride @PBlanchardMD #ASCO2025 #Skincancer #Cutaneouscancer

Congratulations to Dr Elin Jones and all the fundraising community around @HywelDdaHB Bronglais Hospital in opening the new Leri Cancer Unit today 👏 👏 👏 bbc.com/news/articles/…

Congratulations to our fabulous colleague, mentor and friend @LizMiles_RT on winning the #ESTRO25 Interdisciplinary Award. A true supporter of #collaboration and #RTQA. We could not be prouder nor could it be more well deserved!

A pleasure to speak to the @simplyoncology team about head & neck cancer in my podcast debut 😬 Hopefully a patient friendly resource @OracleHNCUK @BAHNOOfficial buzzsprout.com/2342317/episod…

1st part of #Radiotherapy Series that deep dives into #PORT for #Headneckcancer Thanks to @ESTRO_RT and Team led by Profs_Mererid & Vincent with superb colleagues @sueyom @PierluigiBonomo Part 2 on delineation otw! Must read for residents! thegreenjournal.com/article/S0167-…

Incredible study on HNSCC ENI now published in @JCO_ASCO Randomized-controlled trial on ENI dose de-escalation Nominal dose 50 Gy vs. 43 Gy in 34 fractions EQD2 44 Gy vs 34 Gy 6 fractions per week, **NO CHEMOTHERAPY** ascopubs.org/doi/full/10.12…

Fantastic 2 days back at school @SwanseaUni Value Based Health and Care Instensive Learning Academy - lots to process but embedding what matters to @SWWCancerCentre patients in our joint sustainable @SwanseabayNHS @HywelDdaHB strategy and business cases has to be a good start.

Raising the profile of South Wales Spinal Network in primary care land today! @SWSpinalNetwork @HywelDdaHB #CES #MSCC #SpinalInfection

#NationalCancerCNSDay #DyddCNSCanserCenedlaethol @SwanseabayNHS @BaeAbertaweGIG @macmillancancer

@onctrainees Delighted that our abstract on HNSCCUP has been selected for oral presentation. How does involved neck only radiotherapy compare to bilateral neck & mucosal treatment? Find out in Vienna